6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors

Details for Australian Patent Application No. 2004295058 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Wouters, Walter Boudewijn Leopold; Somers, Maria Victorina Francisca; Mabire, Dominique Jean-Pierre; Van Dun, Jacobus Alphonsus Josephus; Guillemont, Jerome Emile Georges

Agent Shelston IP

Pub. Number AU-B-2004295058

PCT Pub. Number WO2005/054201

Priority PCT/EP03/13028 20.11.03 EP; 03078860.8 05.12.03 EP

Filing date 18 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 19 May 2011

International Classifications

C07D 215/227 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 241/44 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 215/22 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/054201 Priority application(s): WO2005/054201

19 May 2011 Application Accepted

  Published as AU-B-2004295058

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295059-6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors

2004295057-7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(ADP-ribose) polymerase inhibitors